Lotte Scheldeman SRL
Lotte Scheldeman reported total assets of 742,475 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jun 2026).
The score of Lotte Scheldeman shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +201 % Total assets +900 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lotte Scheldeman's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jun 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 05 Jul 2024
Lotte Scheldeman's financial analysis
- Solvency21.4%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lotte Scheldeman
Lotte Scheldeman's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0789.481.020
- VAT number
- BE0789481020
- Peppol
- Registered · 0208:0789481020 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Aug 2022
- Registered office
- 2880 Bornem
- Latest accounts
- 2025 · filed on 27 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Lotte Scheldeman (SRL) has been based in Bornem since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 72,057 € and equity of 158,824 €; its revenue is not published. Its solvency stands at 21.4%, below the median of its sector (44.0%).
Companies similar to Lotte Scheldeman
Companies in the same business, of comparable size and area, outside its group.
- VVD SRL Retail sale of pharmaceutical products Ixelles · balance sheet 956,770 €
- J&L Pharma Retail sale of pharmaceutical products Antwerp · balance sheet 664,453 €
- Pharmacie Overlo Retail sale of pharmaceutical products Silly · balance sheet 754,243 €
- Teirlinck Retail sale of pharmaceutical products Londerzeel · balance sheet 694,347 €
- Lunsiefar Retail sale of pharmaceutical products Overijse · balance sheet 839,787 €
- Prieels Pharma Retail sale of pharmaceutical products Oud-Heverlee · balance sheet €1.29m
- Lidefarma Retail sale of pharmaceutical products Lierde · balance sheet 495,027 €
- V-cares Retail sale of pharmaceutical products Zonhoven · balance sheet €1.07m
Frequently asked questions about Lotte Scheldeman
What is the revenue of Lotte Scheldeman?
Lotte Scheldeman files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lotte Scheldeman?
In Belgium, the VAT number is the company number prefixed with BE: BE0789481020 for Lotte Scheldeman, if the company is VAT-registered. Its company number (CBE) is 0789.481.020.
Where is the registered office of Lotte Scheldeman?
According to the CBE register, the registered office of Lotte Scheldeman is in 2880 Bornem.
What is the equity of Lotte Scheldeman?
At the close of the 2025 financial year, the equity of Lotte Scheldeman amounts to 158,824 €, a solvency of 21.4% of total assets.
Who manages Lotte Scheldeman?
The register lists 1 active mandates at Lotte Scheldeman. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lotte Scheldeman
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →